|
A Merck spokesperson comments on their 8.9% price increase since 2008: "Price adjustments for our products have no connection to health care reform." |
While credit card lenders have been increasing fees and interest rates, raising minimum payments and lowering credit limits, drug companies have been busy jacking up their prescription prices too. A recent New York Times investigation knocked the lid off of how drug makers are jacking up wholesale prices--even as inflation goes negative.
From the NY Times piece:
"Even as drug makers promise to support Washington's health care overhaul by shaving $8 billion a year off the nation's drug costs after the legislation takes effect, the industry has been raising its prices at the fastest rate in years.
"In the last year, the industry has raised the wholesale prices of brand-name prescription drugs by about 9 percent, according to industry analysts. That will add more than $10 billion to the nation's drug bill, which is on track to exceed $300 billion this year. By at least one analysis, it is the highest annual rate of inflation for drug prices since 1992."
The 2009 increases mean the average yearly cost for a brand-name prescription drug taken daily would be more than $2,000--a price that's $200 higher than last year. The House healthcare bill that passed on November 7 seeks to cut drug spending by around $14 billion a year over a decade, which would help.
It should register as no surprise that the drug industry is fighting many of the cost-cutting provisions in The Affordable Health Care for America Act, saying they have "valid business reasons for the price increases." We know they do---if you increase prices for consumers, it increases profits for drug companies!







